MD-IMG-Confidence-built-in-spectramax-i3x-gxp_1950x760

Engineered for data integrity in GxP-ready biotech labs

Generate high‑quality, reproducible data with a flexible microplate reader platform designed to support data integrity, traceability, and evolving compliance needs as biotech programs advance.

As biotech programs mature, the expectations placed on data evolve—from informing discovery to supporting decisions that must carry forward into regulated development. The SpectraMax® i3x multi‑mode microplate reader, powered by SoftMax® Pro GxP Software and supported by validation documentation and expert services, is engineered to help GxP‑ready biotech labs generate reproducible, traceable, and defensible data within controlled workflows. By supporting continuity and confidence in data as requirements increase, the SpectraMax i3x platform helps teams progress programs without losing momentum.

Academia-Verdigris_226x226

Data integrity by design

Built to support reproducible, traceable data as biotech programs move toward pre‑GxP or regulated development—without disrupting discovery workflows.
Cost-effective-Verdigris_226x226

Performance that scales

Sensitive, multi‑mode detection with a modular design that allows teams to expand capabilities as assays and data expectations evolve.
GxP-software-Verdigris_226x226

Confident Results

Consistent workflows and reproducible results help teams generate data they can trust—and confidently defend—as programs progress.
Sales-Verdigris_226x226

Validation and Support

SoftMax® Pro GxP Software, validation documentation, and expert support help prepare biotech labs for increasing compliance and data integrity requirements.

Plan your path to GxP-ready workflows

Tell us about your assay needs and development stage. Our specialists will help you evaluate a scalable SpectraMax® i3x workflow designed to support data integrity as your program advances.



From discovery through pre-GxP and regulated development.

Start a GxP-focused consultation

No obligation. Conversations tailored to biotech programs at different stages of development.

Real Scientists. Real Impact.

Screenshot 2026-02-26 at 4.58.32 PM
Screenshot 2026-02-26 at 4.59.01 PM

Molecular Devices: A life science company

We journey alongside researchers, combining next-gen technology and deep expertise to spark bold breakthroughs that push research boundaries and transform lives worldwide.

270,000+

CITATIONS ACROSS OUR
PORTFOLIO

160,000+

SOLUTIONS IN LABS
WORLDWIDE

40

HARDWARE & SOFTWARE
TECHNOLOGY PLATFORM

A trusted life science partner to researchers worldwide

map